CADTH | Evidence Driven
CADTH | Evidence Driven

Rituximab for Pediatric Patients with Primary Membranous Nephropathy: Clinical Effectiveness and Cost-Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1096-000

Question

  1. What is the clinical effectiveness of rituximab compared with current treatments in pediatric patients with membranous nephropathy?
  2. What is the cost-effectiveness of rituximab compared with current treatments in pediatric patients with primary membranous nephropathy?

Key Message

No literature was identified regarding the clinical effectiveness or cost-effectiveness of rituximab compared with current treatments in pediatric patients with membranous nephropathy.

Files

Rituximab for Pediatric Patients with Primary Membranous Nephropathy: Clinical Effectiveness and Cost-Effectiveness Rapid Response March 10, 2020 View PDF
Last Updated : March 18, 2020